Although the weight loss, low levels of blood lipids, and normal insulin sensitivity in the model are not consistent with the clinical metabolic characteristics of NASH, this model is generally considered adequate to study the intrahepatic events including transporters alteration (Clarke et al. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.